Modulation of the organ microenvironment for treatment of cancer metastasis.
about
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinomaAnti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitorUptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituentsFetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cellsSystems biology approach to identification of biomarkers for metastatic progression in cancer.In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation.Antiangiogenic Therapy with Human Apolipoprotein(a) Kringle V and Paclitaxel in a Human Ovarian Cancer Mouse Model.Biobehavioral influences on cancer progression.Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.Upregulation of Toll-like receptor 2 expression in colorectal cancer infected by human cytomegalovirus.Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition processExpression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude miceConsistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseEmerging functions of p21-activated kinases in human cancer cells.Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases.Intravenous KITENIN shRNA injection suppresses hepatic metastasis and recurrence of colon cancer in an orthotopic mouse model.In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis.Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironmentMultiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinomaBlockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomasIntravascular location of breast cancer cells after spontaneous metastasis to the lung.Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancerThe metastatic ability of Ewing's sarcoma cells is modulated by stem cell factor and by its receptor c-kitAn enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell lineStromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice.The challenge of targeting metastasis.Fas and Fas ligand interactions suppress melanoma lung metastasis.Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible geneIntratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors.Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer.Inflammation and stem cells in gastrointestinal carcinogenesis.Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastasesInhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.Metastases to the oral region from pleural mesothelioma: Clinicopathologic review.Orthotopic Esophageal Cancers: Intraesophageal Hyperthermia-enhanced Direct Chemotherapy in Rats.Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines.
P2860
Q21260408-A31108B6-FF92-4AEC-A74E-6CED181F29E6Q28297894-2F48E804-F241-400B-AF5F-BAFEC063DC9BQ28366584-E8D925CA-E3D4-4D2F-9DE8-98BB6460B214Q30429199-7474CCB0-EC8C-40A0-B79B-C498512E4C8EQ33369631-58E3AD3A-5F99-4780-8D95-76CA38BF8339Q33920915-4E40CD9E-2539-4208-A18C-0D0147E1386CQ34092176-FB789699-F686-4D22-855D-D1658C97B87AQ34447713-2F675679-6F0C-434C-859B-B379037AD406Q34551567-CAA83870-B0FD-434C-8092-F9DE005C828BQ34582645-680A2B92-4843-421A-9118-1CAEE907BE23Q34618415-E6833990-62C7-4456-AF25-C7892F9258D7Q34778647-8B3B4DE7-E286-4BC9-84D2-50C154555260Q34917061-176A8ED0-4D21-42CF-A68C-5475FC7E36ECQ34972819-E6224C60-DD22-4B78-ACB2-3025EC4F39D7Q35212402-230EE8C0-55A2-4CFC-BDCD-FF1E90ABCAC2Q35511498-ECAF2850-9482-4CDE-9FA4-D18285CC22A2Q35575178-3798BFC5-0338-4AA4-A64F-519BD63D87ADQ35762215-EF6D8E47-D7DA-413C-9181-5A715CBF0E1CQ35763510-9B486248-2C4F-42C8-B4FA-386E40C2F911Q35764443-24822367-0CD6-471C-8964-9D707F7156BBQ35782383-E4759CB9-AEAE-4309-92D3-34DACF12CE12Q35782463-F4D067DF-A545-4D9B-8561-A84036095634Q35789079-8F43E99F-C033-4DB8-8950-5041B35414BFQ35789093-914869FA-F148-477B-9BAD-162FBA950492Q35829591-CE4DD1D5-2B39-46CA-A486-0A05B33BBAD8Q35829711-2A4C6259-06B9-47C8-9346-43893A9ABA4DQ36141268-BC956BC8-8CD1-4A57-8056-4BDD7B2B7843Q36143628-EF73AB77-AB70-458E-88B3-3393BB4ACF9FQ36322825-6D841920-D4E6-4734-87AB-F939658BF8BEQ36401618-4F981C8D-1DED-41E6-9635-2E8D55C315F6Q36553686-78A17828-206B-4F28-B3D6-1CD5A45F49A0Q36559630-4AD65F08-99CE-4C91-9219-F0107BC67B31Q36623590-404FD25F-51B0-4D2D-A1FB-3A83EFE7B845Q37250475-2F81CDCF-A661-4ABB-9A9D-65A3BA6064EEQ37288557-11E6E23F-2978-4736-9604-2B4FF14487EBQ37367672-0A53937E-8F60-4A6F-B181-BD8AD283031FQ37956213-0501064B-044D-49BB-BA30-CC4EEBB5F9AEQ38893764-522DEA7F-0541-492A-A4A4-1894D3B4DD20Q39108406-302F21F0-1A1A-48B0-B9DC-666813DF12F7Q39514915-3CC75065-A18A-4B0D-A501-6539F819AB4B
P2860
Modulation of the organ microenvironment for treatment of cancer metastasis.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Modulation of the organ microenvironment for treatment of cancer metastasis.
@en
type
label
Modulation of the organ microenvironment for treatment of cancer metastasis.
@en
prefLabel
Modulation of the organ microenvironment for treatment of cancer metastasis.
@en
P356
P1476
Modulation of the organ microenvironment for treatment of cancer metastasis.
@en
P2093
P304
P356
10.1093/JNCI/87.21.1588
P407
P577
1995-11-01T00:00:00Z